A Roche drug that is one of the company’s top cancer products is expanding to autoimmune disease with a new FDA approval in lupus nephritis. The intravenously infused drug, Gazyva, may now be used to ...
Belimumab can reduce the glucocorticoid burden in patients with lupus nephritis, real-world data show. A majority of real-world patients with lupus nephritis (LN) who start belimumab are able to ...
7d
Lupus Advocates Take Action on Capitol Hill to Ensure Access to Care and Increase Research Funding
Hundreds of lupus advocates from 42 states gathered in Washington, DC for the Lupus Foundation of America's National Lupus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results